Methods and Systems for Signal Amplification of Bioassays

• US 20200132685A1
• Filed: 08/21/2019
• Published: 04/30/2020
• Est. Priority Date: 02/21/2012
• Status: Active Application

• Current Assignee: Laboratory Corporation Of America Holdings
• Original Assignee: Laboratory Corporation Of America Holdings
• Inventors: Anderson, Dwight Lyman, Conrad, Andrew J., Erickson, Stephen, Hopkins, Ben Barrett
• Application Number:
  US16/546,647
• Publication Number:
  US 20200132685A1
• Time in Patent Office: Days
• CPC Class Codes: G01N 33/54393 Improving reaction conditions or stability, e.g. by coating or irradiation of surface, by reduction of non-specific binding, by promotion of specific binding

Abstract

Disclosed herein are methods and systems for the detection of an analyte of interest by an amplified assay. The method and systems of the invention utilize the high specificity of biomolecules that have been coupled to a solid support to further amplify a signal produced by the interaction of a binding agent with the analyte of interest as a means to detect low levels of the analyte of interest present in a sample. In certain embodiments, for immunochemical (for example, ELISA or RIA) or immunofluorescence assays in which a protein to be identified is bound directly or through capture antibodies to a passivated surface, amplification of ˜10,000-fold can be achieved.

Claims

1. A method for signal amplification comprising:

adding to the analyte of interest a detection support comprising a solid support comprising a plurality of molecules of a binding agent that recognizes and binds to the analyte of interest; and

detecting at least some of the plurality of binding agent molecules on the detection support.

2. The method of claim 1, wherein the detection support is a bead.

3. The method of claim 1, wherein the detection support comprises a plurality of molecules of a detectable moiety.

4. The method of claim 1, further comprising adding a capture support, the capture support comprising at least one capture support binding agent that recognizes and binds to the analyte of interest so as to immobilize the analyte of interest on the capture support.

5. The method of claim 4, wherein the analyte of interest is bound to the capture support prior to interacting with the detection support.

6. The method of claim 4, wherein the analyte of interest is bound to the capture support after interacting with the detection support.

7. The method of claim 1, further comprising adding a binding agent that can specifically recognize and bind to at least some of the plurality of binding agent molecules on the detection support.

8. The method of claim 7, wherein the binding agent that can specifically recognize and bind to at least some of the plurality of binding agent molecules on the detection support comprises a detectable moiety.

9. The method of claim 4, wherein the capture support is a bead.

10. The method of claim 4, wherein the binding agent attached to the capture support is an antibody or an antibody fragment that can recognize and bind to the analyte of interest.

11. The method of claim 1, wherein the plurality of molecules of the binding agent attached to the detection support are antibodies or antibody fragments that recognize and bind to the analyte of interest.

12. The method of claim 7, wherein the binding agent that can specifically recognize and bind to at least some of the plurality of binding agent molecules on the detection support is an antibody or an antibody fragment.

13. The method of claim 7, wherein the binding agent that can specifically recognize and bind to at least some of the plurality of binding agent molecules on the detection support does not recognize the capture binding agent used to bind the analyte of interest to the capture solid support.

14. The method of claim 7, wherein the binding agent that can specifically recognize and bind to at least some of the plurality of binding agent molecules on the detection support comprises a soluble binding agent.

15. The method of claim 1, wherein the detection support comprises more than 10,000 binding agent molecules specific for the analyte of interest.

16. The method of claim 1, wherein the detection support comprises more than 100,000 binding agent molecules specific for the analyte of interest.

17. A kit for assaying an analyte of interest comprising:

a detection support, the detection support comprising solid support comprising a plurality of molecules of a binding agent that can recognize and bind to the analyte of interest.

18. The kit of claim 17, further comprising a capture support, the capture support comprising at least one capture support binding agent that recognizes and binds to the analyte of interest.

19. The kit of claim 17, further comprising a binding agent that can recognize and bind to the plurality of binding agents on the detection support.

20. The kit of claim 19, wherein the binding agent that can specifically recognize and bind to at least some of the plurality of binding agent molecules on the detection support comprises a soluble binding agent.

21. The kit of claim 17, wherein the detection support is a bead.

22. The kit of claim 17, wherein the detection support comprises a plurality of molecules of a detectable moiety.

23. The kit of claim 17, wherein the plurality of binding agent molecules attached to the detection support are antibodies or antibody fragments that can recognize and bind to the analyte of interest.

24. The kit of claim 18, wherein the capture support is a bead.

25. The kit of claim 18, wherein the capture support binding agent is an antibody or an antibody fragment that can recognize and bind to the analyte of interest.

26. The kit of claim 19, wherein the binding agent that can specifically recognize and bind to at least some of the plurality of binding agent molecules on the detection support is an antibody or an antibody fragment that can recognize and bind to the analyte of interest.

27. The kit of claim 19, wherein the binding agent that can specifically recognize and bind to at least some of the plurality of binding agent molecules on the detection support comprises a detectable moiety.

28. The kit of claim 17, wherein the detection support comprises more than 1,000 binding agent molecules specific for the analyte of interest.

29. The kit of claim 17, wherein the detection support comprises more than 10,000 binding agent molecules specific for the analyte of interest.

30. The kit of claim 17, wherein the detection support comprises more than 100,000 binding agent molecules specific for the analyte of interest.